Raltitrexed
Back to searchMolecule Structure
Scientific Name
Raltitrexed
Description of the Drug
Raltitrexed is a folate analog thymidylate synthase inhibitor used in the treatment of advanced colorectal cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00293
http://www.drugbank.ca/drugs/DB00293
Brand Name(s)
Tomudex
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Thymidylate synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL1952 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL7438 | |||||
| PharmGKB | PA131625240 | |||||
| Human Metabolome Database | HMDB0014438 | |||||
| DrugBank | DB00293 | |||||
| PubChem: Thomson Pharma | 16861576 | 14906899 | 16528454 | |||
| PubChem | 135400182 | |||||
| LINCS | LSM-5952 | |||||
| Nikkaji | J409.820J | |||||
| PDBe | D16 | |||||
| BindingDB | 50027655 | 18795 | ||||
| EPA CompTox Dashboard | DTXSID0046482 | |||||
| DrugCentral | 2353 | |||||
| Brenda | 143744 | 3165 | 32433 | 13332 | 209748 | 247152 |
| ChemicalBook | CB1222070 | |||||
| Guide to Pharmacology | 7403 | |||||
| rxnorm | RALTITREXED | |||||
| PubChem: Drugs of the Future | 12014189 | |||||
| KEGG Ligand | C11372 | |||||
| ChEBI | 5847 | |||||
| ZINC | ZINC000003832372 |
